A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Antibody w/ Western Blot Confirmation
MessageFor Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.
Test Code
LYME
Alias/See Also
6646;
B Burgdorferi;
Borrelia B Earl;
Borrelia Burgdorferi (serum);
Borrelia Burgdorferi Antibodies;
Lyme (serum);
Lyme Disease;
Lime Disease AB Screen (Total),
EIA; Lyme Early;
Lyme IgG & IgM;&nbs
B Burgdorferi;
Borrelia B Earl;
Borrelia Burgdorferi (serum);
Borrelia Burgdorferi Antibodies;
Lyme (serum);
Lyme Disease;
Lime Disease AB Screen (Total),
EIA; Lyme Early;
Lyme IgG & IgM;&nbs
CPT Codes
86618 (reflex 86617(2))
Includes
Western blot confirmation(8593) CPT code(s) 86617x2 performed when screen is positive at an additonal charge.
Preferred Specimen
1 mL serum (minimum 0.5 mL)
Instructions
SST or Red top: Avoid hemolysis. Invert a minimum of 5 times, then allow to clot in an upright position for 30 minutes. Centrifuge the the tube for at least 10 minutes. Keep tightly stoppered.
Transport Container
SST (speckled top), Red top , Plastic Vial (transfer) tube
Transport Temperature
Refrigerated (preferred)
Specimen Stability
Room Temperature = n/a
Refrigerated = 7 days
Frozen = at least 7 days
Refrigerated = 7 days
Frozen = at least 7 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Rejected for gross hemolysis, and lipemia. Microbial contamination may interfere. Plasma will be rejected
Methodology
Enzyme Immunoassay
Setup Schedule
Tuesday and Thursday
BS
BS
Report Available
6 days
Reference Range
SEX | AGE | Report Normals | Units |
N/M/F | 133Y | < OR = 0.90 Negative | |
0.91 - 1.09 Equivocal | |||
> OR = 1.10 Positive | |||
Due to recommendations by the food and drug administration (FDA), all positive or equivocal Borrelia Burgdorferi Antibody EIA (screening) tests will be followed by the western blot. The screening test for B. Burgdorferi has a low predicitive value for a negative result when used to detect early infection and a low predictive value of a positive result when exposure history, symptoms, and clinical findings are not consistent with lyme disease. Positive or equivocal results should not be interpreted as true positives until a second-step testing of the specimen is done using a method that is more specific for antibodies to B. Burgdorferi (e.g. Western Blot). |
Clinical Significance
Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. EIA is the screening test with high sensitivity for antibody detection. Western blot testing qualitatively examines with high specificity antibodies in a patient's specimen. Western blot testing is appropriate for confirming a detected EIA test result.
Performing Laboratory
CompuNet Clinical Laboratories, LLC
2308 Sandridge Drive
Moraine, OH 45439
Last Updated: November 22, 2021